Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat

被引:12
作者
Nekooeian, AA
Tabrizchi, R [1 ]
机构
[1] Mem Univ Newfoundland, Hlth Sci Ctr, Fac Med, St Johns, NF A1B 3V6, Canada
[2] Univ British Columbia, Fac Med, Hlth Sci Ctr 2176, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada
关键词
A(2A) adenosine receptors; acute heart failure; venous resistance; cardiac output; anaesthetized;
D O I
10.1038/sj.bjp.0701764
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of CGS 21680, a selective A(2A) adenosine receptor agonist, on cardiac output, blood pressure, mean circulatory filling pressure (P-mcf), arterial and venous resistances, heart rate and left ventricular end-diastolic pressure were assessed in rats with acute heart failure by means of coronary artery occlusion. 2 Animals (n=6 in each group) were divided into five groups: group I, sham-operated vehicle-treated (0.9% saline; 0.018 mL min(-1)); groups II-V, subject to coronary artery occlusion and treated with vehicle (0.9% saline; 0.018 mL min(-1)) and CGS 21680 (0.1, 0.3 and 1.0 mu g kg(-1) min(-1)), respectively. Haemodynamic measurements were taken one hour after completion of surgery, ninety minutes after coronary artery occlusion (except in group I), and fifteen minutes after infusion of saline or CGS 21680. 3 Baseline haemodynamic measurements before occlusion were found not to differ significantly between the different groups of animals. However, after occlusion, cardiac output, rate of rise in left ventricular pressure (+dP/dt) and blood pressure were significantly reduced when compared to corresponding values in sham-operated animals. In addition, occlusion of the coronary artery resulted in a significant elevation in venous resistance, P-mcf and left ventricular end-diastolic pressure as compared to corresponding values in sham-operated animals. 4 Infusion with CGS 21680 at the highest dose significantly reduced blood pressure, arterial resistance and left ventricular end-diastolic pressure when compared to occluded vehicle-treated animals (group II). Administration of CGS 21680 at the highest dose also significantly increased cardiac output (28%) and heart rate (10%) in comparison to occluded vehicle-treated animals. In addition, the highest dose of CGS 21680 significantly reduced P-mcf (9%) and venous resistance (62%) in comparison to occluded vehicle-treated animals. Administration of CGS 21680 did not significantly affect +dP/dt when compared to occluded vehicle-treated animals. 5 The results from the present investigation indicate that occlusion of the coronary artery in rats results in a state of heart failure characterized by reduced arterial pressure and cardiac output, and increased venous resistance, P-mcf and left ventricular end-diastolic pressure. Administration of CGS 21680 to animals with acute heart failure resulted in increased cardiac output which was due to reduced venous resistance, as well as increased heart rate.
引用
收藏
页码:1666 / 1672
页数:7
相关论文
共 40 条
[1]   ADENOSINE RECEPTOR-MEDIATED RELAXATION OF PORCINE CORONARY-ARTERY IN PRESENCE AND ABSENCE OF ENDOTHELIUM [J].
ABEBE, W ;
MAKUJINA, SR ;
MUSTAFA, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05) :H2018-H2025
[2]   DIFFERENTIAL VASODILATORY ACTION OF 2-OCTYNYLADENOSINE (YT-146), AN ADENOSINE A(2) RECEPTOR AGONIST, IN THE ISOLATED RAT FEMORAL-ARTERY AND VEIN [J].
ABIRU, T ;
ENDO, K ;
MACHIDA, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :9-15
[3]  
COLLIS MG, 1993, TRENDS PHARMACOL SCI, V14, P360
[4]   EFFECTS OF ADENOSINE AND ITS ANALOGS ON THE PERFUSED HINDLIMB ARTERY AND VEIN OF ANESTHETIZED DOGS [J].
COTTERRELL, D ;
KARIM, F .
JOURNAL OF PHYSIOLOGY-LONDON, 1982, 323 (FEB) :473-482
[5]   ADENOSINE RECEPTOR-MEDIATED CORONARY-ARTERY RELAXATION AND CYCLIC-NUCLEOTIDE PRODUCTION [J].
CUSHING, DJ ;
BROWN, GL ;
SABOUNI, MH ;
MUSTAFA, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (02) :H343-H348
[6]   AGE-RELATED-CHANGES IN ADENOSINE AND BETA-ADRENOCEPTOR RESPONSIVENESS OF VASCULAR SMOOTH-MUSCLE IN MAN [J].
FORD, GA ;
HOFFMAN, BB ;
VESTAL, RE ;
BLASCHKE, TF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (01) :83-87
[7]  
FOZARD JR, 1993, N-S ARCH PHARMACOL, V347, P192
[8]   Towards a revised nomenclature for P1 and P2 receptors [J].
Fredholm, BB ;
Abbracchio, MP ;
Burnstock, G ;
Dubyak, GR ;
Harden, TK ;
Jacobson, KA ;
Schwabe, U ;
Williams, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (03) :79-82
[9]  
GLICK MR, 1992, J CARDIOVASC PHARM, V19, P709
[10]   SIMPLE METHOD TO PRODUCE ACUTE HEART-FAILURE BY CORONARY VESSEL EMBOLIZATION IN CLOSED CHEST RATS WITH MICROSPHERES [J].
GORODETSKAYA, EA ;
DUGIN, SF ;
MEDVEDEV, OS ;
ALLABERGENOVA, AE .
JOURNAL OF PHARMACOLOGICAL METHODS, 1990, 24 (01) :43-51